These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 38454010)

  • 21. Glucagon-Like Peptide-1 Receptors in the Gustatory Cortex Influence Food Intake.
    Dossat AM; Kokoska MM; Whitaker-Fornek JR; Sniffen SE; Kulkarni AS; Levitt ES; Wesson DW
    J Neurosci; 2023 Jun; 43(23):4251-4261. PubMed ID: 37127362
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Systemic administration of the long-acting GLP-1 derivative NN2211 induces lasting and reversible weight loss in both normal and obese rats.
    Larsen PJ; Fledelius C; Knudsen LB; Tang-Christensen M
    Diabetes; 2001 Nov; 50(11):2530-9. PubMed ID: 11679431
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Peptide YY and glucagon-like peptide-1 contribute to decreased food intake after Roux-en-Y gastric bypass surgery.
    Svane MS; Jørgensen NB; Bojsen-Møller KN; Dirksen C; Nielsen S; Kristiansen VB; Toräng S; Wewer Albrechtsen NJ; Rehfeld JF; Hartmann B; Madsbad S; Holst JJ
    Int J Obes (Lond); 2016 Nov; 40(11):1699-1706. PubMed ID: 27434221
    [TBL] [Abstract][Full Text] [Related]  

  • 24. When do we eat? Ingestive behavior, survival, and reproductive success.
    Schneider JE; Wise JD; Benton NA; Brozek JM; Keen-Rhinehart E
    Horm Behav; 2013 Sep; 64(4):702-28. PubMed ID: 23911282
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tirzepatide, a dual GIP/GLP-1 receptor co-agonist for the treatment of type 2 diabetes with unmatched effectiveness regrading glycaemic control and body weight reduction.
    Nauck MA; D'Alessio DA
    Cardiovasc Diabetol; 2022 Sep; 21(1):169. PubMed ID: 36050763
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Simultaneous display of sexual and ingestive behaviour by rats.
    Kaplan JM; Bednar I; Södersten P
    J Neuroendocrinol; 1992 Aug; 4(4):381-92. PubMed ID: 21554621
    [TBL] [Abstract][Full Text] [Related]  

  • 27. GLP-1 and weight loss: unraveling the diverse neural circuitry.
    Kanoski SE; Hayes MR; Skibicka KP
    Am J Physiol Regul Integr Comp Physiol; 2016 May; 310(10):R885-95. PubMed ID: 27030669
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Semaglutide and Tirzepatide reduce alcohol consumption in individuals with obesity.
    Quddos F; Hubshman Z; Tegge A; Sane D; Marti E; Kablinger AS; Gatchalian KM; Kelly AL; DiFeliceantonio AG; Bickel WK
    Sci Rep; 2023 Nov; 13(1):20998. PubMed ID: 38017205
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Optimized GIP analogs promote body weight lowering in mice through GIPR agonism not antagonism.
    Mroz PA; Finan B; Gelfanov V; Yang B; Tschöp MH; DiMarchi RD; Perez-Tilve D
    Mol Metab; 2019 Feb; 20():51-62. PubMed ID: 30578168
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association between CLOCK 3111 T/C polymorphism with ghrelin, GLP-1, food timing, sleep and chronotype in overweight and obese Iranian adults.
    Rahati S; Qorbani M; Naghavi A; Nia MH; Pishva H
    BMC Endocr Disord; 2022 Jun; 22(1):147. PubMed ID: 35655162
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A functional neuroimaging review of obesity, appetitive hormones and ingestive behavior.
    Burger KS; Berner LA
    Physiol Behav; 2014 Sep; 136():121-7. PubMed ID: 24769220
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Food preferences and underlying mechanisms after bariatric surgery.
    Behary P; Miras AD
    Proc Nutr Soc; 2015 Nov; 74(4):419-25. PubMed ID: 25990312
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy and Safety of Glucagon-Like Peptide-1 Receptor Agonists on Body Weight and Cardiometabolic Parameters in Individuals With Obesity and Without Diabetes: A Systematic Review and Meta-Analysis.
    Ansari HUH; Qazi SU; Sajid F; Altaf Z; Ghazanfar S; Naveed N; Ashfaq AS; Siddiqui AH; Iqbal H; Qazi S
    Endocr Pract; 2024 Feb; 30(2):160-171. PubMed ID: 38029929
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Macronutrient intake, appetite, food preferences and exocrine pancreas function after treatment with short- and long-acting glucagon-like peptide-1 receptor agonists in type 2 diabetes.
    Quast DR; Nauck MA; Schenker N; Menge BA; Kapitza C; Meier JJ
    Diabetes Obes Metab; 2021 Oct; 23(10):2344-2353. PubMed ID: 34189834
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A Review of Incretin Therapies Approved and in Late-Stage Development for Overweight and Obesity Management.
    Chetty AK; Rafi E; Bellini NJ; Buchholz N; Isaacs D
    Endocr Pract; 2024 Mar; 30(3):292-303. PubMed ID: 38122931
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical Impact of Glucagon-Like Peptide-1 Receptor Analogs on the Complications of Obesity.
    Yazıcı D; Yapıcı Eser H; Kıyıcı S; Sancak S; Sezer H; Uygur M; Yumuk V
    Obes Facts; 2023; 16(2):149-163. PubMed ID: 36349778
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The association between glucagon-like peptide-1 receptor agonists (GLP-1 RAs) and suicidality: reports to the Food and Drug Administration Adverse Event Reporting System (FAERS).
    McIntyre RS; Mansur RB; Rosenblat JD; Kwan ATH
    Expert Opin Drug Saf; 2024 Jan; 23(1):47-55. PubMed ID: 38087976
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sex-divergent effects of hindbrain GLP-1-producing neuron activation in rats.
    Lopez-Ferreras L; Asker M; Krieger JP; Skibicka KP
    Front Neurosci; 2023; 17():1265080. PubMed ID: 37942137
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Glucagon-Like Peptide 1 Receptor Agonists: A Medication for Obesity Management.
    Taha MB; Yahya T; Satish P; Laird R; Agatston AS; Cainzos-Achirica M; Patel KV; Nasir K
    Curr Atheroscler Rep; 2022 Aug; 24(8):643-654. PubMed ID: 35624390
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of GLP-1 and Its Analogs on Gastric Physiology in Diabetes Mellitus and Obesity.
    Maselli DB; Camilleri M
    Adv Exp Med Biol; 2021; 1307():171-192. PubMed ID: 32077010
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.